Meta AnalysisID 6670

舒肝解郁汤治疗冠心病伴抑郁症的疗效与安全性评价

CRD42022353121

本研究系统评价或描述性分析了舒干洁玉汤在冠心病合并抑郁症治疗中的临床疗效及应用。

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Formula: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
6670
Evidence Id
15228
Core Evidence Id
15228
Source Meta Analysis Id
6652
Herb2 Meta Analysis Id
HBMA006652
Crd Id
CRD42022353121
Title
Efficacy and safety evaluation of Shugan Jieyu Decoction in treating coronary heart disease with depression
Review Question
本研究系统评价或描述性分析了舒干洁玉汤在冠心病合并抑郁症治疗中的临床疗效及应用。
Study Type Included
We only included the Chinese and English clinical randomized controlled trials published from January 2012 to January 2022.
Condition Being Studied
Coronary heart disease and depression are the main problems that endanger human health worldwide. Epidemiological studies have shown that depression is a psychological risk factor for coronary heart disease, and nearly 30% of patients with affective disorders have coronary heart disease .The strong association between depression and coronary artery disease has led many to recommend universal screening for depression in all patients with coronary artery disease and endorsed by the American Psychiatric Association . There is a bidirectional causal relationship between psychological and somatic factors and the pathogenesis of coronary artery disease.
Participant
Patients with coronary heart disease and depression
Animal
Human Disease Modelled
Intervention
The experimental group was treated with Shugan Jieyu Decoction, and the control group was treated with conventional western medicine. The experimental group was treated with conventional western medicine + Shugan Jieyu Decoction, and the control group was treated with conventional western medicine.
Comparator Control
Conventional western drugs are aspirin, nitrates, beta-blockers, and statins. Clopidogrel is given in patients with unstable coronary artery disease, and nitroglycerin 0.5 mg is included during angina attacks. The batch, dose, administration time, and course of treatment of the two groups were not limited.
Main Outcome
The total effective rate of angina pectoris and depression improved; Total effective rate = (total cases - invalid cases) /total cases ×100%.
Outcome Measure
Additional Outcome
SDS score, HAMD score, and CPR and HCY test index scores.
Study Method
Systematic review
Keyword
Coronary Disease; Depression; Depressive Disorder; Humans; Phytotherapy
Contact
LI Zhenzhen [email protected]
Organisational Affiliation
shandong university of tranditional Chinese medicine
Funding Source
his work was supported by the National Natural Science Foundation of China (82074293) and the Key Project of the Shandong Provincial Natural Science Foundation (ZR2020ZD17). Grant number(s) <span style=font-size: 14px>State the funder, grant or award number and the date of award</span> 82074293 zr2020ZD17
Other Selection Criteria
Final Publication
Same Topic Review
Published Protocol
Review Type
Language
English
Country
China
Review Stage
Review Ongoing
First Submission Date
2022-08-12
Registration Date
2022-08-22
Anticipated Start Date
2022-06-16
Anticipated Completion Date
2022-09-10
Title Cn
舒肝解郁汤治疗冠心病伴抑郁症的疗效与安全性评价
Title En
Efficacy and safety evaluation of Shugan Jieyu Decoction in treating coronary heart disease with depression
Bilingual Status
complete